You Are Here: Home > About Arthritis > Arthritis in the News

News

    Apply Filters Clear All
     
    supplement news article

    Feb 05

    Research shows significant regional differences in access to arthritis medications across Canada The Conference Board of Canada released a report today, funded by the Arthritis Society, titled Accessing Arthritis Medications—A Pan-Canadian Analysis. The analyses presented in this report show that patients’ access to and the cost of arthritis medications differ by jurisdiction and... Public
    supplement news article

    Jan 31

    Sensors set stage for happier patients post-op By combining wearable sensors with machine learning, Western Medical Biophysics and Surgery professor Matthew Teeter is helping patients with arthritis better understand their present conditions in order to have realistic expectations for life after surgery. Teeter was recently honoured by the... Public
    supplement news article

    Jan 08

    AbbVie Receives Health Canada Approval of new oral RA Medication RINVOQ® (upadacitinib) Inflammatory forms of arthritis can be aggressive, and in the absence of a cure, medication can play a vital role in the treatment plan,. Patients and their physicians need access to a variety of treatment options. The Arthritis Society welcomes the approval of new treatments that expand the... Newswire.ca
    supplement news article

    Jan 07

    Arthritis Matters - January 2020 New year, new youJanuary is a great time to introduce changes that can improve your overall health and ultimately your ability to cope with the challenges of arthritis. Check out these articles for simple tips you can incorporate into your daily life.Eating healthy foodsWalking to stay... Arthritis Society
    supplement news article

    Dec 12

    Alberta will force patients to switch from biologics to cheaper biosimilar medications Globe and Mail coverage of the Alberta biosimilars announcement, highlighting some (non-arthritis) patient groups' concerns. The Globe and Mail
    supplement news article

    Dec 12

    Biosimilar drugs to provide safe, effective treatment The Alberta Government is changing coverage for biologics under the Alberta Drug Benefit List (ABDL). Public coverage for patients currently on certain originator biologics will be transitioned to biosimilars. This affects both patients who are new to biologics, and patients already receiving... Public
    supplement news article

    Dec 11

    Innovative Medicines Canada bans members from paying doctors fees for IV infusions Pharmaceutical companies will no longer be allowed to pay fees to Canadian doctors for overseeing intravenous infusions of their medications under a revised ethical code written by the industry group for brand-name drug makers. The goal is to remove incentives that encourage doctors to prescribe... The Globe and Mail
    supplement news article

    Dec 10

    Province turns to private sector for help reducing surgery wait times Alberta is increasing public funding to non-hospital surgical clinics to address the serious backlog in joint replacement surgeries in that province. Addressing wait times is one of our key areas of advocacy focus: arthritis is the leading cause of joint replacement surgeries, including 99% of... Calgary Herald
    supplement news article

    Nov 22

    A look at medical cannabis coverage’s growing pains After the Arthritis Society’s extensive advocacy for medical cannabis research, it seemed only natural for the organization to cover the drug under its employee benefits plan. Features an interview with our COO, Cheryl McClellan, talking about our employee benefits solution. Public
     |<  <  2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11  >  >| 
    Load More